Skip Navigation

JNCI Journal of the National Cancer Institute 1996 88(5):270-278; doi:10.1093/jnci/88.5.270
© 1996 by Oxford University Press
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hawkins, M. M.
Right arrow Articles by Stovall, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hawkins, M. M.
Right arrow Articles by Stovall, M. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 88, No. 5, 270-278, March 6, 1996
© 1996 Oxford University Press

Radiotherapy, Alkylating Agents, and Risk of Bone Cancer After Childhood Cancer

Michael M. Hawkins, L. Margaret Kinnier Wilson, Hazel S. Burton, Michael H. N. Potok, David L. Winter, H. Basil Marsden, Marilyn A. Stovall

Childhood Cancer Research Group, University of Oxford U.K.
Department of Paediatnc Pathology, Royal Manchester Children's Hospital Pendlebury, U.K.
The University of Texas M. D. Anderson Cancer Center Houston

Correspondence to: M. M. Hawkins. D.Phil., Childhood Cancer Research Group. University of Oxford. 57 Woodstock Rd., Oxford OX2 6HJ. U.K.

BACKGROUND: Individuals who had cancer in childhood are at higher risk of developing bone cancer than any other type of second primary cancer.

PURPOSE: Using the population-based National Registry of Childhood Tumours in Britain, we investigated the incidence and etiology of second primary bone cancer after childhood cancer in a cohort study and in a case–control study.

METHODS: A cohort study of 13 175 3-year survivors of childhood cancer diagnosed in Britain between 1940 and 1983 revealed 55 subsequent bone cancers. A largely nested case–control study comprised 59 case subjects developing second primary bone cancer, and 220 control subjects were selected and matched for sex, type of first cancer, age at first cancer, and interval between diagnosis of first cancer and subsequent bone cancer. Outcome measures were the incidence of bone cancer after childhood cancer, the cumulative dose of radiation received at the site of the second bone cancer in the case subject and at the corresponding anatomic site in the matched control subjects, and the cumulative dose of alkylating agents and vinca alkaloids received by case and control subjects.

RESULTS: The percentage of 3-year survivors developing bone cancer within 20 years did not exceed 0.9%, except following heritable retinoblastoma (7.2%), Ewing's sarcoma (5.4%), and other malignant bone tumors (2.4%). The risk of bone cancer increased substantially with increased cumulative dose of radiation to the bone (P<.001, linear trend). At the highest levels of exposure, however, the risk appeared to decline somewhat (P = .065, nonlinearity). Exposure to less than 10 Gy was, at worst, associated with only a small increased relative risk (RR) of bone cancer (RR = 0.7; 95% confidence interval = 0.2–2.2). The risk of bone cancer increased linearly (P = .04, one-tailed test) with increased cumulative dose of alkylating agents.

IMPLICATIONS: This population-based study provides grounds for reassurance of the majority of survivors in that their risk of developing bone cancer within 20 years of 3-year survival did not exceed 0.9%. The higher risks found for bone cancer following the other specific rare types of childhood cancer provide a rational basis for surveillance. The RRs reported for bone cancer after specified levels of exposure to radiation should help in making decisions concerning future treatment protocols. [J Natl Cancer Inst 1996;88:270–8]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
M. M. Hudson, D. A. Mulrooney, D. C. Bowers, C. A. Sklar, D. M. Green, S. S. Donaldson, K. C. Oeffinger, J. P. Neglia, A. T. Meadows, and L. L. Robison
High-Risk Populations Identified in Childhood Cancer Survivor Study Investigations: Implications for Risk-Based Surveillance
J. Clin. Oncol., May 10, 2009; 27(14): 2405 - 2414.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A.-M. Tsimberidou, S. Wen, P. McLaughlin, S. O'Brien, W. G. Wierda, S. Lerner, S. Strom, E. J Freireich, L. J. Medeiros, H. M. Kantarjian, et al.
Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
J. Clin. Oncol., February 20, 2009; 27(6): 904 - 910.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
W. Landier and S. Bhatia
Cancer Survivorship: A Pediatric Perspective
Oncologist, November 1, 2008; 13(11): 1181 - 1192.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. C. Bluhm, C. Ronckers, R. J. Hayashi, J. P. Neglia, A. C. Mertens, M. Stovall, A. T. Meadows, P. A. Mitby, J. A. Whitton, S. Hammond, et al.
Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study
Blood, April 15, 2008; 111(8): 4014 - 4021.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Guerin, M. Hawkins, A. Shamsaldin, C. Guibout, I. Diallo, O. Oberlin, L. Brugieres, and F. de Vathaire
Treatment-Adjusted Predisposition to Second Malignant Neoplasms After a Solid Cancer in Childhood: A Case-Control Study
J. Clin. Oncol., July 1, 2007; 25(19): 2833 - 2839.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Maule, G. Scelo, G. Pastore, P. Brennan, K. Hemminki, E. Tracey, R. Sankila, E. Weiderpass, J. H. Olsen, M. L. McBride, et al.
Risk of Second Malignant Neoplasms After Childhood Leukemia and Lymphoma: An International Study
J Natl Cancer Inst, May 16, 2007; 99(10): 790 - 800.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. D. Dickerman
The Late Effects of Childhood Cancer Therapy
Pediatrics, March 1, 2007; 119(3): 554 - 568.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
T. O. Henderson, J. Whitton, M. Stovall, A. C. Mertens, P. Mitby, D. Friedman, L. C. Strong, S. Hammond, J. P. Neglia, A. T. Meadows, et al.
Secondary Sarcomas in Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study
J Natl Cancer Inst, February 21, 2007; 99(4): 300 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
L. B. Travis
The Epidemiology of Second Primary Cancers
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2020 - 2026.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. S. Fenske, C. McMahon, D. Edwin, J. C. Jarvis, J. M. Cheverud, M. Minn, V. Mathews, M. A. Bogue, M. A. Province, H. L. McLeod, et al.
Identification of candidate alkylator-induced cancer susceptibility genes by whole genome scanning in mice.
Cancer Res., May 15, 2006; 66(10): 5029 - 5038.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. A. Kleinerman, M. A. Tucker, R. E. Tarone, D. H. Abramson, J. M. Seddon, M. Stovall, F. P. Li, and J. F. Fraumeni Jr
Risk of New Cancers After Radiotherapy in Long-Term Survivors of Retinoblastoma: An Extended Follow-Up
J. Clin. Oncol., April 1, 2005; 23(10): 2272 - 2279.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
S. Bhatia
Cancer Survivorship--Pediatric Issues
Hematology, January 1, 2005; 2005(1): 507 - 515.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Bhatia, Y. Yasui, L. L. Robison, J. M. Birch, M. K. Bogue, L. Diller, C. DeLaat, F. Fossati-Bellani, E. Morgan, O. Oberlin, et al.
High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin's Disease: Report From the Late Effects Study Group
J. Clin. Oncol., December 1, 2003; 21(23): 4386 - 4394.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. M. Dores, C. Metayer, R. E. Curtis, C. F. Lynch, E. A. Clarke, B. Glimelius, H. Storm, E. Pukkala, F. E. van Leeuwen, E. J. Holowaty, et al.
Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin's Disease: A Population-Based Evaluation Over 25 Years
J. Clin. Oncol., August 15, 2002; 20(16): 3484 - 3494.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
W H. B Wallace, A. Blacklay, C. Eiser, H. Davies, M. Hawkins, G. A Levitt, and M. E M Jenney
Regular review: Developing strategies for long term follow up of survivors of childhood cancer
BMJ, August 4, 2001; 323(7307): 271 - 274.
[Full Text] [PDF]

Home page
 JCOHome page
G. Socie, R. E. Curtis, H. J. Deeg, K. A. Sobocinski, A. H. Filipovich, L. B. Travis, K. M. Sullivan, P. A. Rowlings, D. W. Kingma, P. M. Banks, et al.
New Malignant Diseases After Allogeneic Marrow Transplantation for Childhood Acute Leukemia
J. Clin. Oncol., January 14, 2000; 18(2): 348 - 348.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. T. Schneider, E. Hilgenfeld, D. Schwabe, W. Behnisch, A. Zoubek, R. Wessalowski, and U. Gobel
Acute Myelogenous Leukemia After Treatment for Malignant Germ Cell Tumors in Children
J. Clin. Oncol., October 1, 1999; 17(10): 3226 - 3233.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M.-D. Tabone, P. Terrier, H. Pacquement, M. Brunat-Mentigny, C. Schmitt, A. Babin-Boilletot, H. H. Mahmoud, and C. Kalifa
Outcome of Radiation-Related Osteosarcoma After Treatment of Childhood and Adolescent Cancer: A Study of 23 Cases
J. Clin. Oncol., September 1, 1999; 17(9): 2789 - 2789.
[Abstract] [Full Text] [PDF]

Home page
 Br J OphthalmolHome page
C Levy, F Doz, E Quintana, H Pacquement, J Michon, P Schlienger, P Validire, B Asselain, L Desjardins, and J M Zucker
Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results
Br J Ophthalmol, October 1, 1998; 82(10): 1154 - 1158.
[Abstract] [Full Text]

Home page
 Mol. Cell. Biol.Home page
A. B. Niculescu III, X. Chen, M. Smeets, L. Hengst, C. Prives, and S. I. Reed
Effects of p21Cip1/Waf1 at Both the G1/S and the G2/M Cell Cycle Transitions: pRb Is a Critical Determinant in Blocking DNA Replication and in Preventing Endoreduplication
Mol. Cell. Biol., January 1, 1998; 18(1): 629 - 643.
[Abstract] [Full Text]

Home page
 JAMAHome page
F. L. Wong, J. D. Boice Jr, D. H. Abramson, R. E. Tarone, R. A. Kleinerman, M. Stovall, M. B. Goldman, J. M. Seddon, N. Tarbell, J. F. Fraumeni Jr, et al.
Cancer Incidence After Retinoblastoma: Radiation Dose and Sarcoma Risk
JAMA, October 15, 1997; 278(15): 1262 - 1267.
[Abstract] [PDF]

Home page
 NEJMHome page
R. E. Curtis, P. A. Rowlings, H. J. Deeg, D. A. Shriner, G. Socie, L. B. Travis, M. M. Horowitz, R. P. Witherspoon, R. N. Hoover, K. A. Sobocinski, et al.
Solid Cancers after Bone Marrow Transplantation
N. Engl. J. Med., March 27, 1997; 336(13): 897 - 904.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
L. L Robison
Second primary cancers after childhood cancer
BMJ, April 6, 1996; 312(7035): 861 - 862.
[Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.